Project Details
Description
Protocol MS-LAQ-301: A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the safety, tolerability and efficacy o
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/07 → 12/31/11 |
Funding
- TEVA NEUROSCIENCE, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.